Acquiring, developing and commercializing transformative medicines in neuroscience.
We aim to become an elite innovative neuroscience company addressing China specific unmet medical needs with top notch development and commercial capabilities.
We aspire to bridge the gap of innovative neuroscience treatments between China and global leaders by bringing their breakthrough therapies to make patient lives better in China and Asia
We are led by a world-class neuroscience veteran team with proven track records and repeated successes in developing and commercializing CNS drugs in China and Asia
We are backed by top-tier biotech venture capitals with broad network worldwide, in-depth knowledge and unprecedent track records in new venture incubation in China.